AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15775731 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of unopposed transdermal 17beta‐estradiol and intermittent medroxyprogesterone acetate (MPA) after 12 months
Number of subjects: 99
Study 15775731 — intervention group
Group type: EXPERIMENTAL
Intervention: Unopposed transdermal 17beta‐estradiol and MPA
Number of subjects: 99
Study 15775731 — intervention group
Group type: COMPARATOR
Intervention: HRT (Hormone Replacement Therapy)
Number of subjects: 99
Study 12066081 — intervention group
Group type: EXPERIMENTAL
Intervention: Comfeel (Coloplast, UK)
Number of subjects: 0
Study 12066081 — intervention group
Group type: EXPERIMENTAL
Intervention: Granuflex improved formulation (Convatec, UK)
Number of subjects: 0
Study 12066081 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutinova foam (Beiersdorf Medical, UK)
Number of subjects: 0
Study 12066081 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 9532435 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical magnetic stimulation to the right hemisphere at a delay of 25 ms
Number of subjects: 5
Study 9532435 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical magnetic stimulation to the left hemisphere at delays of 50 and 75 ms
Number of subjects: 5
Study 9532435 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical magnetic stimulation (general)
Number of subjects: 5
Study 7640157 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin (broad spectrum antibiotic) administered for 2 days
Number of subjects: 10
Study 7640157 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified, but implied to be without antibiotic treatment)
Number of subjects: 10
Study 2679220 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific IgG antibodies
Number of subjects: 30
Study 2679220 — intervention group
Group type: COMPARATOR
Intervention: Non-specific IgG
Number of subjects: 30
Study 1087138 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer factor
Number of subjects: 26
Study 1087138 — intervention group
Group type: COMPARATOR
Intervention: Combination chemotherapy
Number of subjects: 26
Study 30219249 — intervention group
Group type: EXPERIMENTAL
Intervention: Supragingival scaling
Number of subjects: 50
Study 30219249 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental restoration under local anesthesia (LA)
Number of subjects: 50
Study 30219249 — intervention group
Group type: EXPERIMENTAL
Intervention: Exodontia under local anesthesia (LA)
Number of subjects: 50
Study 27929333 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulation group (writing about deepest feelings and coping efforts)
Number of subjects: 96
Study 27929333 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional disclosure group (writing about deepest thoughts and feelings)
Number of subjects: 96
Study 27929333 — intervention group
Group type: COMPARATOR
Intervention: Cancer-fact group (writing about facts relevant to cancer experience)
Number of subjects: 96
Study 26474447 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized wellness program including a limited genetic profile, psychosocial assessment, and high-intensity coaching
Number of subjects: 0
Study 26474447 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 23157935 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet (4.1 g [105 mEq] potassium/2,100 kcal/d)
Number of subjects: 412
Study 23157935 — intervention group
Group type: COMPARATOR
Intervention: Control diet (1.7 g [43 mEq] potassium/2,100 kcal/d)
Number of subjects: 412
Study 21492728 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic surgery
Number of subjects: 48
Study 21492728 — intervention group
Group type: COMPARATOR
Intervention: External ventricular drainage (EVD)
Number of subjects: 48
Study 19032700 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured psychoeducational intervention (n = 38) consisting of monthly sessions for 9 months
Number of subjects: 76
Study 19032700 — intervention group
Group type: COMPARATOR
Intervention: Routine out-patient care (n = 38) for the same duration
Number of subjects: 76
Study 16409530 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 1.5 mg/kg i.v. before induction of general anesthesia
Number of subjects: 60
Study 16409530 — intervention group
Group type: COMPARATOR
Intervention: Ilioinguinal and iliohypogastric nerve block with 0.5% bupivacaine (0.25 ml/kg) before skin incision
Number of subjects: 60
Study 14974267 — intervention group
Group type: EXPERIMENTAL
Intervention: New preparation for wound edge protection
Number of subjects: 0
Study 14974267 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 12964282 — intervention group
Group type: EXPERIMENTAL
Intervention: Allevyn (Smith and Nephew)
Number of subjects: 6
Study 12964282 — intervention group
Group type: EXPERIMENTAL
Intervention: Biatain (Coloplast)
Number of subjects: 6
Study 12964282 — intervention group
Group type: EXPERIMENTAL
Intervention: Lyofoam (Seton Scholl)
Number of subjects: 6
Study 12964282 — intervention group
Group type: EXPERIMENTAL
Intervention: Tielle (Johnson and Johnson)
Number of subjects: 6
Study 8970187 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide [67% N2O‐33% O2 (vol/vol)]
Number of subjects: 14
Study 8970187 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 14
Study 8970187 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide [67% N2O‐33% O2 (vol/vol)] in orthopedic procedures
Number of subjects: 14
Study 8970187 — intervention group
Group type: COMPARATOR
Intervention: Control group (fasted for 10 hrs, no anesthesia)
Number of subjects: 14
Study 7953035 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Support Team (CST)
Number of subjects: 82
Study 7953035 — intervention group
Group type: COMPARATOR
Intervention: Generic CPN care
Number of subjects: 82
Study 3591604 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum cholesterol and triglyceride levels, HDL cholesterol, LDL cholesterol measurements
Number of subjects: 4524
Study 3591604 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum cholesterol and LDL to HDL cholesterol ratio
Number of subjects: 4524
Study 29625599 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy School Start Plus intervention
Number of subjects: 352
Study 29625599 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 352
Study 28219315 — intervention group
Group type: EXPERIMENTAL
Intervention: Resident teaching as small group facilitators in the Patient Safety course
Number of subjects: 184
Study 28219315 — intervention group
Group type: EXPERIMENTAL
Intervention: Residents with small group facilitation training in Y3
Number of subjects: 184
Study 25604688 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity focused ultrasound (HIFU) cyclocoagulation, group 1 (4 seconds duration)
Number of subjects: 52
Study 25604688 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity focused ultrasound (HIFU) cyclocoagulation, group 2 (6 seconds duration)
Number of subjects: 52
Study 23635614 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention with pulmonary recruitment maneuver and intraperitoneal normal saline infusion
Number of subjects: 100
Study 23635614 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 21118366 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet for 12 months
Number of subjects: 31
Study 18923220 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral midazolam (0.5 mg/kg)
Number of subjects: 20
Study 18923220 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ketamine (5 mg/kg)
Number of subjects: 20
Study 16626607 — intervention group
Group type: EXPERIMENTAL
Intervention: Alvimopan 12 mg (n = 413)
Number of subjects: 519
Study 16626607 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 106)
Number of subjects: 519
Study 14664877 — intervention group
Group type: EXPERIMENTAL
Intervention: Video information in addition to the standard consultation
Number of subjects: 31
Study 14664877 — intervention group
Group type: COMPARATOR
Intervention: Conventional consultation (no video)
Number of subjects: 31
Study 14664877 — intervention group
Group type: EXPERIMENTAL
Intervention: Video information
Number of subjects: 31
Study 14664877 — intervention group
Group type: EXPERIMENTAL
Intervention: Video information and standard consultation
Number of subjects: 31
Study 10793878 — intervention group
Group type: EXPERIMENTAL
Intervention: E2 1 mg/NETA 0.25 mg
Number of subjects: 135
Study 10793878 — intervention group
Group type: EXPERIMENTAL
Intervention: E2 1 mg/NETA 0.5 mg
Number of subjects: 135
Study 10793878 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 9387527 — intervention group
Group type: EXPERIMENTAL
Intervention: 3,4-dihydroxyacetophynone (DHAP)
Number of subjects: 22
Study 9387527 — intervention group
Group type: COMPARATOR
Intervention: Normal pregnant controls
Number of subjects: 22
Study 9387527 — intervention group
Group type: COMPARATOR
Intervention: PIH group
Number of subjects: 22
Study 1435165 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (2 puffs = 200 micrograms)
Number of subjects: 7
Study 1435165 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 1435165 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 7
Study 4016829 — intervention group
Group type: EXPERIMENTAL
Intervention: Netilmicin-clindamycin
Number of subjects: 53
Study 4016829 — intervention group
Group type: COMPARATOR
Intervention: Tobramycin-clindamycin
Number of subjects: 53
Study 29705485 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 90
Study 29705485 — intervention group
Group type: COMPARATOR
Intervention: Footbath
Number of subjects: 90
Study 29705485 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 90
Study 27287856 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib 85 mg/m2 daily
Number of subjects: 25
Study 27287856 — intervention group
Group type: COMPARATOR
Intervention: Etoposide 50 mg/m2/day for 21 days
Number of subjects: 25
Study 24888739 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose Nevirapine
Number of subjects: 0
Study 24888739 — intervention group
Group type: COMPARATOR
Intervention: Conventional tests
Number of subjects: 0
Study 22885982 — intervention group
Group type: EXPERIMENTAL
Intervention: VARIETY - four highly‐liked fruits served over 4, 7‐min courses
Number of subjects: 20
Study 22885982 — intervention group
Group type: COMPARATOR
Intervention: NON‐VARIETY - participants received their most highly‐liked fruit (fruit 1) for each of the four courses
Number of subjects: 20
Study 20594372 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsidized artemisinin-based combination therapies (ACTs)
Number of subjects: 0
Study 20594372 — intervention group
Group type: COMPARATOR
Intervention: Shops stocking ACTs
Number of subjects: 0
Study 20594372 — intervention group
Group type: COMPARATOR
Intervention: Other antimalarial drugs
Number of subjects: 0
Study 18238985 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical staging
Number of subjects: 0
Study 18238985 — intervention group
Group type: COMPARATOR
Intervention: Preoperative imaging
Number of subjects: 0
Study 18238985 — intervention group
Group type: COMPARATOR
Intervention: Gross examination of depth of myometrial invasion
Number of subjects: 0
Study 18238985 — intervention group
Group type: COMPARATOR
Intervention: Postoperative adjuvant pelvic radiation therapy
Number of subjects: 0
Study 18238985 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative treatment for childbearing
Number of subjects: 0
Study 15785909 — intervention group
Group type: EXPERIMENTAL
Intervention: C-loop haptics
Number of subjects: 50
Study 15785909 — intervention group
Group type: COMPARATOR
Intervention: Z haptics
Number of subjects: 50
Study 12571693 — intervention group
Group type: EXPERIMENTAL
Intervention: Administration of acetylsalicylic acid
Number of subjects: 0
Study 12571693 — intervention group
Group type: EXPERIMENTAL
Intervention: Administration of beta-blockers
Number of subjects: 0
Study 12571693 — intervention group
Group type: EXPERIMENTAL
Intervention: Administration of angiotensin-converting enzyme inhibitors
Number of subjects: 0
Study 12571693 — intervention group
Group type: EXPERIMENTAL
Intervention: Administration of thrombolytics
Number of subjects: 0
Study 12571693 — intervention group
Group type: EXPERIMENTAL
Intervention: Administration of statins
Number of subjects: 0
Study 12571693 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality for AMI
Number of subjects: 0
Study 12571693 — intervention group
Group type: EXPERIMENTAL
Intervention: Readmissions for AMI
Number of subjects: 0
Study 12571693 — intervention group
Group type: EXPERIMENTAL
Intervention: Readmissions for unstable angina
Number of subjects: 0
Study 12571693 — intervention group
Group type: EXPERIMENTAL
Intervention: Readmissions for congestive heart failure
Number of subjects: 0
Study 12571693 — intervention group
Group type: EXPERIMENTAL
Intervention: Median length of stay in the emergency department
Number of subjects: 0
Study 12571693 — intervention group
Group type: EXPERIMENTAL
Intervention: Median waiting times for cardiac catheterization
Number of subjects: 0
Study 12571693 — intervention group
Group type: EXPERIMENTAL
Intervention: Median waiting times for percutaneous coronary intervention
Number of subjects: 0
Study 12571693 — intervention group
Group type: EXPERIMENTAL
Intervention: Median waiting times for coronary artery bypass graft surgery
Number of subjects: 0
Study 10491502 — intervention group
Group type: EXPERIMENTAL
Intervention: Effidrate cream (glycerol alkyl-ether) applied on one side of the face
Number of subjects: 20
Study 10491502 — intervention group
Group type: COMPARATOR
Intervention: Control side (no treatment)
Number of subjects: 20
Study 8902681 — intervention group
Group type: EXPERIMENTAL
Intervention: Tx-1 = 1.0 MHz at 1.5 W/cm2
Number of subjects: 20
Study 8902681 — intervention group
Group type: EXPERIMENTAL
Intervention: Tx-2 = 1.0 MHz at 1.0 W/cm2
Number of subjects: 20
Study 8902681 — intervention group
Group type: EXPERIMENTAL
Intervention: Tx-5 = sham
Number of subjects: 20
Study 8902681 — intervention group
Group type: EXPERIMENTAL
Intervention: Tx-3 = 3.0 MHz at 1.2 W/cm2
Number of subjects: 20
Study 8902681 — intervention group
Group type: EXPERIMENTAL
Intervention: Tx-4 = 3.0 MHz at 1.0 W/cm2
Number of subjects: 20
Study 8902681 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study 1671008 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol-atropine infusion
Number of subjects: 0
Study 1671008 — intervention group
Group type: COMPARATOR
Intervention: Prazosin
Number of subjects: 0
Study 7034932 — intervention group
Group type: EXPERIMENTAL
Intervention: PACE (cisplatin, doxorubicin, cyclophosphamide, and vindesine)
Number of subjects: 74
Study 7034932 — intervention group
Group type: COMPARATOR
Intervention: PCE (cisplatin, cyclophosphamide, and vindesine)
Number of subjects: 74
Study 31667661 — intervention group
Group type: EXPERIMENTAL
Intervention: Cre8
Number of subjects: 60
Study 31667661 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomatrix
Number of subjects: 60
Study 31667661 — intervention group
Group type: EXPERIMENTAL
Intervention: Xience
Number of subjects: 60
Study 31667661 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 60
Study 30973204 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal insulin-supported oral antidiabetic drugs therapy (BOT)
Number of subjects: 290
Study 30973204 — intervention group
Group type: COMPARATOR
Intervention: Oral antidiabetic drugs (OADs)
Number of subjects: 290
Study 26923199 — intervention group
Group type: EXPERIMENTAL
Intervention: PATHS (Promoting Alternative Thinking Strategies) curriculum
Number of subjects: 568
Study 26923199 — intervention group
Group type: COMPARATOR
Intervention: Usual practices (Control group)
Number of subjects: 568
Study 25928515 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrarectal ice application 5 minutes before procedure
Number of subjects: 120
Study 25928515 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine gel 10 mL applied 10 minutes before procedure
Number of subjects: 120
Study 23348933 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip exercise at 30% of maximal contraction for 6-8 minutes
Number of subjects: 53
Study 21465229 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine/paclitaxel
Number of subjects: 147
Study 21465229 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine/carboplatin
Number of subjects: 147
Study 21465229 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine/cisplatin
Number of subjects: 147
Study 21465229 — intervention group
Group type: COMPARATOR
Intervention: Overall survival and progression-free survival
Number of subjects: 147
Study 19734378 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture (830 nm, 10 mW, Ga-Al-As laser diode)
Number of subjects: 100
Study 19734378 — intervention group
Group type: COMPARATOR
Intervention: Sham laser
Number of subjects: 100
Study 19734378 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture
Number of subjects: 100
Study 18209230 — intervention group
Group type: EXPERIMENTAL
Intervention: Leisure-time physical activity
Number of subjects: 3514
Study 18209230 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivation to change lifestyle behaviors
Number of subjects: 3514
Study 15159318 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled diet with 5 servings (750 g) of fruits and vegetables daily
Number of subjects: 40
Study 15159318 — intervention group
Group type: COMPARATOR
Intervention: Controlled diet with 2 servings (300 g) of fruits and vegetables daily
Number of subjects: 40
Study 15142508 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B
Number of subjects: 0
Study 15142508 — intervention group
Group type: COMPARATOR
Intervention: Conventional amphotericin B
Number of subjects: 0
Study 15142508 — intervention group
Group type: COMPARATOR
Intervention: Voriconazol
Number of subjects: 0
Study 10427231 — intervention group
Group type: EXPERIMENTAL
Intervention: Complementary therapies
Number of subjects: 0
Study 10427231 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 8528169 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon‐alpha post‐transplant
Number of subjects: 33
Study 8528169 — intervention group
Group type: COMPARATOR
Intervention: Melphalan (200 mg/m2) and methylprednisolone (1.5 g x 5) for conditioning
Number of subjects: 33
Study 8528169 — intervention group
Group type: COMPARATOR
Intervention: Higher levels of paraprotein (> 10 milligrams) at the time of transplant
Number of subjects: 33
Study 8528169 — intervention group
Group type: COMPARATOR
Intervention: Patients who ultimately cleared paraprotein
Number of subjects: 33
Study 2292631 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted attention retraining program
Number of subjects: 29
Study 2292631 — intervention group
Group type: COMPARATOR
Intervention: Memory training program (control)
Number of subjects: 29
Study 7321973 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroalcoholic preparation (Brondecon elixir)
Number of subjects: 8
Study 7321973 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-free preparation (Nuelin syrup)
Number of subjects: 8
Study 7321973 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both preparations
Number of subjects: 8
Study 31658542 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-negative pressure treatment
Number of subjects: 64
Study 31658542 — intervention group
Group type: COMPARATOR
Intervention: Silver sulfadiazine cream with dressing change every other day
Number of subjects: 64
Study 27925676 — intervention group
Group type: EXPERIMENTAL
Intervention: Carfilzomib at doses ranging from 15 to 20/56 mg/m2, administered as an intravenous infusion on 2 consecutive days each week for 3 weeks (days 1, 2, 8, 9, 15, and 16).
Number of subjects: 0
Study 27925676 — intervention group
Group type: EXPERIMENTAL
Intervention: Carfilzomib at 20/56 mg/m2 as a 30-minute infusion for monotherapy and combination therapy.
Number of subjects: 0
Study 26888240 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of semilunar coronally advanced flap (SCAF) and button technique
Number of subjects: 12
Study 26888240 — intervention group
Group type: COMPARATOR
Intervention: Semilunar coronally advanced flap (SCAF) alone
Number of subjects: 12
Study 24464530 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (2 × 20 mg)
Number of subjects: 20
Study 24464530 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 22999835 — intervention group
Group type: EXPERIMENTAL
Intervention: Families for Safe Dates program
Number of subjects: 324
Study 19490626 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine nasal spray (NNS) used hourly (intervention group)
Number of subjects: 50
Study 19490626 — intervention group
Group type: COMPARATOR
Intervention: Nicotine nasal spray (NNS) used ad libitum (control group)
Number of subjects: 50
Study 17305695 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral trioxide aggregate (MTA) used for apexification in one appointment
Number of subjects: 50
Study 15070877 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine vaginal gel
Number of subjects: 0
Study 15070877 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine paracervical block
Number of subjects: 0
Study 12160817 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine 2% jelly
Number of subjects: 50
Study 12160817 — intervention group
Group type: COMPARATOR
Intervention: BSS
Number of subjects: 50
Study 9659024 — intervention group
Group type: EXPERIMENTAL
Intervention: Group D (13.5 ml at 12 ml.min‐1)
Number of subjects: 140
Study 9659024 — intervention group
Group type: EXPERIMENTAL
Intervention: Large volumes of local anaesthetic
Number of subjects: 140
Study 9659024 — intervention group
Group type: COMPARATOR
Intervention: Rate of injection and volume of local anaesthetic
Number of subjects: 140
Study 7640328 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term cannabis use (duration measured in years)
Number of subjects: 0
Study 7640328 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term cannabis use (frequency measured in use per time period)
Number of subjects: 0
Study 31809601 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab treatment
Number of subjects: 0
Study 31809601 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 31524161 — intervention group
Group type: EXPERIMENTAL
Intervention: ReadClear (assistive reading app)
Number of subjects: 20